Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
17.30
-0.84 (-4.63%)
At close: Dec 5, 2025, 4:00 PM EST
17.10
-0.20 (-1.16%)
After-hours: Dec 5, 2025, 7:56 PM EST
Xencor Market Cap
Xencor has a market cap or net worth of $1.24 billion as of December 5, 2025. Its market cap has decreased by -25.29% in one year.
Market Cap
1.24B
Enterprise Value
719.60M
1-Year Change
-25.29%
Ranking
Category
Stock Price
$17.30
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.24B, an increase of 403.42%. That is a compound annual growth rate of 14.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.24B | -23.18% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |